Cocamide DEA vs Permethrin for Head Lice (NCT02500524) | Clinical Trial Compass
TerminatedPhase 3
Cocamide DEA vs Permethrin for Head Lice
Stopped: Lack of efficacy
United Kingdom44 participantsStarted 1998-07
Plain-language summary
To assess the efficacy and safety of 10% Cocamide DEA and Lyclear creme rinse (permethrin1%) in the eradication of head lice. To assess the ability of each product to kill all viable ova and to assess patient acceptability of the product in use.
Who can participate
Age range4 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male and female patients over the age of 4 who are found to have a head lice infection.
* Patients who give written informed consent or, if the patient is under 16 years of age, whose guardian gives written informed consent to participate in the study.
* Available for the duration of study i.e. 15 days.
Exclusion Criteria:
* Patients with a known sensitivity to pyrethroid, organophosphate, and/or carbamate insecticides, sensitivity to chrysanthemums and/or known sensitivity to paraben preservatives.
* Patients who have been treated with other head lice products within the last 4 weeks.
* Patients who have undergone a course of antibiotic treatment within the last 4 weeks.
* Patients who have any persistent skin disorder of the scalp (i.e. eczema, chronic dermatitis, psoriasis).
* Patients with asthma
* Patients whose hair has been bleached, colour treated or permed within the last 4 weeks.
* Pregnant or nursing mothers.
* Patients who have participated in another clinical trial within 1 month prior to entry to this study.
* Patients who have already participated in this clinical trial.